The Bavarian Nordic in talks to expand production of monkeypox vaccine
Content of the article LONDON – Bavarian Nordic, the Danish company behind the vaccine being used to try to stem a global outbreak of monkeypox, is in talks to potentially expand production capacity, its chief executive said on Monday. The Copenhagen-based vaccine maker has a product under the brand name Jynneos, Imvamune or Imvanex depending …
The Bavarian Nordic in talks to expand production of monkeypox vaccine Read More »